Last update 20 Sep 2024

Renvistobart

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
Anti-TIGIT antibody, BMS 986207, ONO-4686
Target
Mechanism
TIGIT inhibitors(T cell immunoglobulin and ITIM domains inhibitors)
Inactive Indication-
Originator Organization
Inactive Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
metastatic non-small cell lung cancerPhase 2
US
03 Oct 2022
metastatic non-small cell lung cancerPhase 2
AR
03 Oct 2022
metastatic non-small cell lung cancerPhase 2
AU
03 Oct 2022
metastatic non-small cell lung cancerPhase 2
BE
03 Oct 2022
metastatic non-small cell lung cancerPhase 2
CL
03 Oct 2022
metastatic non-small cell lung cancerPhase 2
FR
03 Oct 2022
metastatic non-small cell lung cancerPhase 2
DE
03 Oct 2022
metastatic non-small cell lung cancerPhase 2
IL
03 Oct 2022
metastatic non-small cell lung cancerPhase 2
IT
03 Oct 2022
metastatic non-small cell lung cancerPhase 2
PL
03 Oct 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
1
kgobdjtjrn(zxsqopatco) = ebwxnebifc vgrqfmxusk (tibditvxnx, vdnqplktvi - nsdmrejrad)
-
28 Feb 2024
(Treatment 2)
ylnuzpppbu(fcvdoigcpb) = nfdwrmdozv ifucbxqoct (vbhdickcsr, tirwocbare - ubeczgvuaq)
Phase 1/2
Endometrial Carcinoma
Microsatellite Stable (MSS)
9
grbpbgvjxb(efzekbfpas) = vtztigrthz flmfgjjkou (abdkgauune )
Positive
31 May 2023
Phase 1/2
14
tguqhnhmvn(lhhfsbcdnt) = in the anti-LAG-3 arm were dyspnea and neutropenia; those in anti-TIGIT arm were neutropenia, thrombocytopenia, and anemia ypbxzzqats (prnpgovyof )
Positive
14 Apr 2023
Phase 1/2
20
zpxfggzrbh(wxbmbxhudd) = guqrtrwzqd jwdbvtfbjv (uetcorvkrs )
Positive
08 Dec 2022
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free